Infinity Pharmaceuticals, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-12-13: Reporting owner Perkins Adelene Q; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-12-13: Reporting owner Lindblom Christopher M; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-12-13: Reporting owner ADAMS JULIAN; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-12-13: Reporting owner Holtzman Steven H; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-12-13 | Perkins Adelene Q Officer (EVP and Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −128,000 128,000 owned after | $9.80 exercise price | 2007-12-14 | |
| 2007-12-13 | Lindblom Christopher M Officer (Assistant Treasurer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,885 3,885 owned after | $9.80 exercise price | 2007-12-14 | |
| 2007-12-13 | ADAMS JULIAN Officer (President, R&D & CSO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +111,200 111,200 owned after | $9.80 exercise price | 2007-12-14 | |
| 2007-12-13 | Holtzman Steven H Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +167,000 167,000 owned after | $9.80 exercise price | 2007-12-14 | |
| 2007-09-12 | LEVINE ARNOLD J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $9.23 exercise price | 2007-09-14 | |
| 2007-09-12 | SATO VICKI L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $9.23 exercise price | 2007-09-14 | |
| 2007-09-12 | ROSENMAN HERM Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $9.23 exercise price | 2007-09-14 | |
| 2007-09-12 | EVNIN ANTHONY B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,875 1,875 owned after | $9.23 exercise price | 2007-09-13 | |
| 2007-06-04 | Daniel D Ronald Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,875 1,875 owned after | $10.92 exercise price | 2007-06-06 | |
| 2007-01-25 | Perkins Adelene Q Officer (CFO and Treasurer) | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $13.59 exercise price | 2007-01-29 | |
| 2007-01-25 | ADAMS JULIAN Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $13.59 exercise price | 2007-01-29 | |
| 2007-01-25 | Holtzman Steven H Director, Officer (CEO and Assistant Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $13.59 exercise price | 2007-01-29 |